Transcriptomics

Dataset Information

0

CFTR acts as a potential therapeutic target for attention deficit-hyperactivity disorder


ABSTRACT: The occurrence of attention deficit-hyperactivity disorder (ADHD) symptoms in patients with cystic fibrosis (CF) is substantially higher than in the general population, and the cystic fibrosis transmembrane conductance regulator (CFTR) is the pathogenic gene of cystic fibrosis, suggesting the potentially critical role of CFTR in ADHD. Here, we identified three heterozygous missense mutations (p.E217G, p.F316L and p.T1220I) in CFTR, segregating with ADHD in two consanguineous families with 6 affected individuals. Using the zebrafish model, we found that the cftr knockout line displays hyperactive, impulsive-like, and attention deficit-like behaviors, reminiscent of human ADHD patients. Single-cell RNA-seq of 7 dpf larvae identified clusters of neuron cells that were sensitive to cftr, especially, the number of dopaminergic neuron cells decreased in the cftr mutant fish. Bulk RNA-seq and proteomic analysis at the early gastrulation period showed that the expression of nerve system genes was abnormal. Notably, we tried to use CFTR activitors Lumacaftor (VX-809) and Ivacaftor (VX-770) to treat the ADHD zebrafish model (established by per1b mutant), and found enhanced CFTR activity could rescue the ADHD-like behaviors. In brief, we uncover the role of CFTR in ADHD pathogenesis and explore novel diagnoses and therapy for ADHD by targeting CFTR.

ORGANISM(S): Danio rerio

PROVIDER: GSE284214 | GEO | 2024/12/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-09-18 | PXD039773 | Pride
2022-05-04 | PXD032836 | Pride
2024-01-26 | PXD042481 | Pride
2019-01-03 | GSE124548 | GEO
2022-08-11 | PXD028355 | Pride
2019-05-11 | GSE129168 | GEO
2022-08-11 | PXD028393 | Pride
2014-09-05 | E-GEOD-52889 | biostudies-arrayexpress
2014-06-30 | GSE30470 | GEO
2014-09-05 | GSE52889 | GEO